Cat.#: ASSD-171
Description | Ionomycin calcium salt is a potent calcium ionophore that shows selectivity for Ca2+ over Mg2+ and K+. The compound acts as a Ca2+ carrier and is the calcium salt of ionomycin. Ionomycin can enhance Ca2+ influx and increase intracellular Ca2+ concentration. Also induces apoptosis. |
Size | 1mg, 5mg |
Chemical Name | (4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-11,19,21-Trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-10,16-docosadienoic acid calcium salt |
Molecule Weight | 747.08 |
Molecular formula | C41H70CaO9 |
CAS Number | 56092-82-1 |
PubChem identifier | 6446270 |
MDL Number | MFCD00083634 |
Purity | >98% |
Solubility | Soluble in ethanol (100 mM) and DMSO (25 mM) |
Form | White to off-white |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-144 | Oxazole Yellow Iodide (AC144) | 1 mg | inquiry |
ASSD-209 | Tetramethylrhodamine isothiocyanate Isomer R (AC209) | 5 mg, 10 mg | inquiry |
ASSD-196 | 5-Carboxyfluorescein (AC196) | 100 mg, 250 mg | inquiry |
ASSD-167 | Fura-2 AM (Cell permeant) (AC167) | 1 mg | inquiry |
ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
ASSD-104 | Hoechst 33258 (AC104) | 25 mg, 100 mg | inquiry |
ASSD-200 | Ethylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[3-difluoromethyl-4-phosphoanilinamidosuccinic Acid] Diamide (AC200) | 500 μg | inquiry |
ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
ASSD-180 | Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 (AC180) | 1 mg | inquiry |
We are committed to accelerating progress in stroke research and drug development.